Nasdaq
TSHA
Taysha Gene Therapies, Inc.
- Health Care
- Listed 2020
- 1 day
- −1.9%
- 1 month
- −2.5%
- 1 year
- +127%
$6.34 · Mkt cap $1.82B
At the 6 Aug 2026 close
Nasdaq
Taysha Gene Therapies, Inc.
$6.34 · Mkt cap $1.82B
At the 6 Aug 2026 close
Taysha Gene Therapies, Inc. trades under the ticker TSHA on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2020. Its market capitalisation is $1.82B. The last closing price was $6.34, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +127%, and −2.5% over the past month. Returns are price returns and exclude dividends.
This page exists because TSHA is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.